118 related articles for article (PubMed ID: 2545794)
1. Carcinoembryonic antigen levels in germ cell tumours.
Hitchins RN; Rustin GJ; Mitchell HD; Newlands ES; Begent RH; Bagshawe KD
Int J Biol Markers; 1989; 4(1):31-4. PubMed ID: 2545794
[TBL] [Abstract][Full Text] [Related]
2. Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.
Motawy MS; Szymendera JJ; al-Jazzaf H; Behbehani AE; Foudeh MO; Ebraheem AK; Nasralla MY; Ali MA
Int J Biol Markers; 1992; 7(2):80-6. PubMed ID: 1378875
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
4. Alphafetoprotein and germ cell neoplasms.
Hayatnagarkar NP; Deshpande AD; Solanki BR
Indian J Med Res; 1980 Aug; 72():269-72. PubMed ID: 6164638
[No Abstract] [Full Text] [Related]
5. Non-seminomatous germ cell tumors of the testis. Analysis of CEA production in primary tumors and in retroperitoneal lymph node metastases after PVB chemotherapy.
Suurmeijer AJ; Oosterhuis JW; Marrink J; Ockhuizen T; Sleijfer DT; Schraffordt Koops H; Fleuren GJ
Eur J Cancer Clin Oncol; 1984 May; 20(5):601-8. PubMed ID: 6203752
[TBL] [Abstract][Full Text] [Related]
6. Alpha-foetoprotein and carcinoembryonic antigen in germ cell neoplasms.
Talerman A; van der Pompe WB; Haije WG; Baggerman L; Boekestein-Tjahjadi HM
Br J Cancer; 1977 Mar; 35(3):288-91. PubMed ID: 66925
[TBL] [Abstract][Full Text] [Related]
7. [Tumor markers in germ cell tumors. Clinical use and research aspects].
Clausen PP; Nørgaard-Pedersen B; Arends J; Ingild A; Jacobsen GK; Jacobsen M; Juhl BR; Kjaersgaard E; Nissen MH; Schultz-Larsen P; Toftager-Larsen K; Zeuthen J
Ugeskr Laeger; 1982 May; 144(18):1285-90. PubMed ID: 6181594
[No Abstract] [Full Text] [Related]
8. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
[No Abstract] [Full Text] [Related]
9. [Evaluation of plasma tumor markers in germinal tumors of the testis].
Blacker C; Feinstein MC; Roger M; Zimmer R; Scholler R
Ann Med Interne (Paris); 1984; 135(5):376-80. PubMed ID: 6207755
[TBL] [Abstract][Full Text] [Related]
10. Profiles of epitope-defined markers in sera from patients with testicular germ cell tumors.
Yamamoto H; Rudén U; Esposti P; Hirano K; Stigbrand T; Andersson L; Hisazumi H; Wahren B
Urol Res; 1988; 16(1):31-6. PubMed ID: 2449757
[TBL] [Abstract][Full Text] [Related]
11. The significance of alpha-fetoprotein in the serum of patients with malignant teratomas and related gonadal neoplasms.
Ballas M
Ann Clin Lab Sci; 1974; 4(4):267-75. PubMed ID: 4142543
[TBL] [Abstract][Full Text] [Related]
12. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).
Talerman A; Haije WG; Baggerman L
Int J Cancer; 1977 Jun; 19(6):741-6. PubMed ID: 68937
[TBL] [Abstract][Full Text] [Related]
14. High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours.
Dieckmann KP; Hennig F; Anheuser P; Gehrckens R; Viehweger F; Wülfing C; Belge G
Urol Int; 2021; 105(1-2):21-26. PubMed ID: 33049748
[TBL] [Abstract][Full Text] [Related]
15. Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
McAleer JJ; Nicholls J; Horwich A
Eur J Cancer; 1992; 28A(4-5):825-8. PubMed ID: 1381929
[TBL] [Abstract][Full Text] [Related]
16. Residual retroperitoneal tumour tissue in patients treated for metastatic non-seminomatous testicular germ cell tumours: an immunohistochemical investigation.
Jacobsen GK; Olsen J
Tumour Biol; 1985; 6(1):25-35. PubMed ID: 2410971
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.
Khoo SK; MacKay EV
Br J Obstet Gynaecol; 1976 Oct; 83(10):753-9. PubMed ID: 990213
[TBL] [Abstract][Full Text] [Related]
18. Placental alkaline phosphatase, alphafetoprotein and carcinoembryonic antigen in testicular tumors. Tissue typing by means of cytologic smears.
Wahren B; Holmgren PA; Stigbrand T
Int J Cancer; 1979 Dec; 24(6):749-53. PubMed ID: 94592
[TBL] [Abstract][Full Text] [Related]
19. The significance of measurement of human placental lactogen, human chorionic gonadotropin, and carcinoembryonic antigen in patients with ovarian carcinoma.
Samaan NA; Smith JP; Rutledge FN; Schultz PN
Am J Obstet Gynecol; 1976 Sep; 126(2):186-9. PubMed ID: 183504
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
Balzer BL; Ulbright TM
Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
